Oncology (Williston Park, N.Y.)

Keyphrases

Publications

volume 37, number 1, 2023

Richard L Martin, Stephen Schleicher
Progressing From Disparity to Equity: Untangling the Complexities of Timely Care and the Rural Cancer Experience. Oncology (Williston Park, N.Y.) 37 (1) (2023)
Qianyue Deng, Yingjie Zhang, Yanying Li, Ting Mei, Xuexi Yang, Xiaoman Tian, Xianyan Chen, Youling Gong
Survival of Patients With Inoperable Non-Small Cell Lung Cancer With Baseline Severe Pulmonary Dysfunction: Impacts of Thoracic Radiotherapy and Predictive Analysis for Acute Radiation Pneumonitis. Oncology (Williston Park, N.Y.) 37 (1) (2023)
Qianyue Deng, Yingjie Zhang, Yanying Li, Ting Mei, Xuexi Yang, Xiaoman Tian, Xianyan Chen, Youling Gong
Survival of Patients With Inoperable Non-Small Cell Lung Cancer With Baseline Severe Pulmonary Dysfunction: Impacts of Thoracic Radiotherapy and Predictive Analysis for Acute Radiation Pneumonitis. Oncology (Williston Park, N.Y.) 37 (1) (2023)
Minh-Tri Nguyen, Wei Wei, Gregory Cooper, Alok A Khorana, Suneel Kamath
Shorter Time to Treatment Is Associated With Improved Survival in Rural Patients With Breast Cancer Despite Other Adverse Socioeconomic Factors. Oncology (Williston Park, N.Y.) 37 (1) (2023)
Minh-Tri Nguyen, Wei Wei, Gregory Cooper, Alok A Khorana, Suneel Kamath
Shorter Time to Treatment Is Associated With Improved Survival in Rural Patients With Breast Cancer Despite Other Adverse Socioeconomic Factors. Oncology (Williston Park, N.Y.) 37 (1) (2023)

volume 37, number 10, 2023

Samia Asif, Brendan J Hurley, Sehr Haroon, Subodh Lele, Bhavina Sharma
Unusual Clinical Presentation of Clear Cell Sarcoma in a Young Woman. Oncology (Williston Park, N.Y.) 37 (10) (2023)
Ludovic Saba, Kevin S Landau, Silvia Bunting, Chakra P Chaulagain
Secondary Pure Red Cell Aplasia During Daratumumab/ Hyaluronidase Therapy for Multiple Myeloma. Oncology (Williston Park, N.Y.) 37 (10) (2023)

volume 37, number 11, 2023

Sahith Kumar Shetty, Vidya G Doddawad, Shyam Sundar, Shivananda S
Exploring the Changing Diagnostic Criteria of Gorlin-Goltz Syndrome: A Case Report. Oncology (Williston Park, N.Y.) 37 (11) (2023)

volume 37, number 2, 2023

Julia Dai, Madeleine Duvic
Cutaneous T-Cell Lymphoma: Current and Emerging Therapies. Oncology (Williston Park, N.Y.) 37 (2) (2023)
Fareed Khawaja, Marilyne Daher, Amy Spallone, Roy F Chemaly
COVID-19 Vaccination in Patients With Cancer and Recipients of Cellular Therapy. Oncology (Williston Park, N.Y.) 37 (2) (2023)

volume 37, number 3, 2023

Javier Orozco-Mera, Fernando Peralta-Pizza, Oscar Escobar-Vidarte, Brenda Coll-Tello, Aurelio Ariza
Signaling Pathways in the Relapse of Glioblastoma. Oncology (Williston Park, N.Y.) 37 (3) (2023)
David L DeRemer, Bently P Doonan
Evaluating Treatment Options and the Multidisciplinary Care of Ocular Toxicities of MEK Inhibitors. Oncology (Williston Park, N.Y.) 37 (3) (2023)
David L DeRemer, Bently P Doonan
Evaluating Treatment Options and the Multidisciplinary Care of Ocular Toxicities of MEK Inhibitors. Oncology (Williston Park, N.Y.) 37 (3) (2023)
Jing Han, Juejing Chen, Hanqiong Zhou, Lidan Hao, Qiming Wang
Ocular Toxicities of MEK Inhibitors in Patients With Cancer: A Systematic Review and Meta-analysis. Oncology (Williston Park, N.Y.) 37 (3) (2023)
David L DeRemer, Bently P Doonan
Evaluating Treatment Options and the Multidisciplinary Care of Ocular Toxicities of MEK Inhibitors. Oncology (Williston Park, N.Y.) 37 (3) (2023)

volume 37, number 4, 2023

Zhubin J Gahvari, Natalie S Callander
The Management of Relapsed and Refractory Multiple Myeloma. Oncology (Williston Park, N.Y.) 37 (4) (2023)
Daniel Vt Catenacci, Yoon-Koo Kang, Hope E Uronis, Keun-Wook Lee, Matthew Ch Ng, Peter C Enzinger, Se Hoon Park, Philip J Gold, Jill Lacy, Howard S Hochster, Sang Cheul Oh, Yeul Hong Kim, Kristen A Marrone, Ronan J Kelly, Rosalyn A Juergens, Jong Gwang Kim, Thierry Alcindor, Sun Jin Sym, Eun-Kee Song, Cheng Ean Chee, Yee Chao, Sunnie Kim, Do-Youn Oh, Jennifer Yen, Justin I Odegaard, Errin Lagow, Daner Li, Jichao Sun, Patrick Kaminker, Paul A Moore, Minori Koshiji Rosales, Haeseong Park
Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/ Gastroesophageal Adenocarcinoma. Oncology (Williston Park, N.Y.) 37 (4) (2023)
James J Driscoll, James Ignatz-Hoover
Emerging Strategies to Manage Relapsed and/or Refractory Multiple Myeloma. Oncology (Williston Park, N.Y.) 37 (4) (2023)
Daniel Vt Catenacci, Yoon-Koo Kang, Hope E Uronis, Keun-Wook Lee, Matthew Ch Ng, Peter C Enzinger, Se Hoon Park, Philip J Gold, Jill Lacy, Howard S Hochster, Sang Cheul Oh, Yeul Hong Kim, Kristen A Marrone, Ronan J Kelly, Rosalyn A Juergens, Jong Gwang Kim, Thierry Alcindor, Sun Jin Sym, Eun-Kee Song, Cheng Ean Chee, Yee Chao, Sunnie Kim, Do-Youn Oh, Jennifer Yen, Justin I Odegaard, Errin Lagow, Daner Li, Jichao Sun, Patrick Kaminker, Paul A Moore, Minori Koshiji Rosales, Haeseong Park
Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/ Gastroesophageal Adenocarcinoma. Oncology (Williston Park, N.Y.) 37 (4) (2023)
Zhubin J Gahvari, Natalie S Callander
The Management of Relapsed and Refractory Multiple Myeloma. Oncology (Williston Park, N.Y.) 37 (4) (2023)
Daniel Vt Catenacci, Yoon-Koo Kang, Hope E Uronis, Keun-Wook Lee, Matthew Ch Ng, Peter C Enzinger, Se Hoon Park, Philip J Gold, Jill Lacy, Howard S Hochster, Sang Cheul Oh, Yeul Hong Kim, Kristen A Marrone, Ronan J Kelly, Rosalyn A Juergens, Jong Gwang Kim, Thierry Alcindor, Sun Jin Sym, Eun-Kee Song, Cheng Ean Chee, Yee Chao, Sunnie Kim, Do-Youn Oh, Jennifer Yen, Justin I Odegaard, Errin Lagow, Daner Li, Jichao Sun, Patrick Kaminker, Paul A Moore, Minori Koshiji Rosales, Haeseong Park
Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/ Gastroesophageal Adenocarcinoma. Oncology (Williston Park, N.Y.) 37 (4) (2023)
James J Driscoll, James Ignatz-Hoover
Emerging Strategies to Manage Relapsed and/or Refractory Multiple Myeloma. Oncology (Williston Park, N.Y.) 37 (4) (2023)

volume 37, number 5, 2023

Hans Kristian Nugraha, I Gede Eka Wiratnaya, Putu Astawa
An Arthroscopic Approach for the Intralesional Curettage of Giant Cell Tumor of the Distal Femur: A Case Report. Oncology (Williston Park, N.Y.) 37 (5) (2023)
Arshiya Mariam, Suneel Kamath, Kimberly Schveder, Howard L McLeod, Daniel M Rotroff
Biomarkers for Response to Anti-PD-1/Anti-PD-L1 Immune Checkpoint Inhibitors: A Large Meta-Analysis. Oncology (Williston Park, N.Y.) 37 (5) (2023)
Ben Kong
The Complexities and Art of Interpreting Biomarkers and Response to Immune Checkpoint Inhibitors. Oncology (Williston Park, N.Y.) 37 (5) (2023)

volume 37, number 6, 2023

Syed Arslan Shehzad Shah, Naveed Ahmed Mahar, Harris Hassan Qureshi, Muddasir Hussain, Gauhar Sultan, Rehan Mohsin, Altaf Hashmi
Squamous Cell Carcinoma of the Kidney: A Large Case Series. Oncology (Williston Park, N.Y.) 37 (6) (2023)
Kirollos Hanna
Erdafitinib's Road to Approval and Use in Urothelial Carcinoma. Oncology (Williston Park, N.Y.) 37 (6) (2023)
Francisco Javier Castro-Alonso, Evelyn Beas-Lozano, Yuly A Remolina-Bonilla, Thomas W Flaig, María T Bourlon
Erdafitinib in the Treatment of Metastatic Urothelial Carcinoma. Oncology (Williston Park, N.Y.) 37 (6) (2023)

volume 37, number 7, 2023

Ankita Aggarwal, Mackenzie Taychert, Louay Hasanin, Donald Doll, Mira Gabrielle Basuino, Hassan Hasanein
Erdheim-Chester Disease: A Case Report of BRAF V600E-Negative, MAP2K1-Positive ECD Diagnosed by Blood Next-Generation Sequencing Assay and a Brief Literature Review. Oncology (Williston Park, N.Y.) 37 (7) (2023)
Allen M Chen
De-Escalation Treatment for Human Papillomavirus-Related Oropharyngeal Cancer: Questions for Practical Consideration. Oncology (Williston Park, N.Y.) 37 (7) (2023)

volume 37, number 8, 2023

Rohit Gupta, Joshua Hirsch, Maya Guhan, Jeffrey Triska, Ruben Hernaez, Addison Taylor
Unusual Initial Presentation of Hepatocellular Carcinoma as a Clavicular Head Mass. Oncology (Williston Park, N.Y.) 37 (8) (2023)
null Avyakta Kallam Md, Julie M Vose
Current Treatments in Mantle Cell Lymphoma. Oncology (Williston Park, N.Y.) 37 (8) (2023)

volume 37, number 9, 2023

Fatma Betül Ayrak, Süheyla Aytaç Arslan, Yılmaz Tezcan
Spinal ATRT and Radiotherapy Case Report in an Adult Man. Oncology (Williston Park, N.Y.) 37 (9) (2023)

volume 36, number 12, 2023

Omran Saifi, Bradford S Hoppe
Radiation Therapy in Diffuse Large B-Cell Lymphoma: A Little Boost Gets You Over the Finish Line. Oncology (Williston Park, N.Y.) 36 (12) (2023)
Omran Saifi, Bradford S Hoppe
Radiation Therapy in Diffuse Large B-Cell Lymphoma: A Little Boost Gets You Over the Finish Line. Oncology (Williston Park, N.Y.) 36 (12) (2023)
Omran Saifi, Bradford S Hoppe
Radiation Therapy in Diffuse Large B-Cell Lymphoma: A Little Boost Gets You Over the Finish Line. Oncology (Williston Park, N.Y.) 36 (12) (2023)

volume 36, number 5, 2022

Sunita D Nasta
Making Progress in PTCL: Significant Unmet Needs. Oncology (Williston Park, N.Y.) 36 (5) (2022)

volume 36, number 6, 2022

Meghana Kesireddy, Matthew Lunning
Relapsed or Refractory Diffuse Large B-Cell Lymphoma: "Dazed and Confused". Oncology (Williston Park, N.Y.) 36 (6) (2022)
Rahiya Rehman, Gabriel Solorzano, Rachel Heist, Stephanie N Thompson, Mohamad Badawi
Predictors of Poor Adherence to Follow-up Care in Survivors of Childhood Cancer. Oncology (Williston Park, N.Y.) 36 (6) (2022)
Bendu Konneh, Austin J Leonard, John T Lafin, Liwei Jia, Aditya Bagrodia
Management of Testicular Germ Cell Tumor With Somatic-Type Malignancy. Oncology (Williston Park, N.Y.) 36 (6) (2022)

volume 36, number 7, 2022

Shelia Lahijani
Bridging the Gaps: Taking Care of the Whole Person. Oncology (Williston Park, N.Y.) 36 (7) (2022)
Stacy Stein, Kirsten Dooley, Nataliya V Ubohla, Howard S Hochster
A Pilot Study of Omalizumab to Treat Oxaliplatin-Induced Hypersensitivity Reaction. Oncology (Williston Park, N.Y.) 36 (7) (2022)
Kimberley R Doucette, David H Vesole
Recent Advancements and Future Directions in Frontline Treatment of Multiple Myeloma. Oncology (Williston Park, N.Y.) 36 (7) (2022)
Veronica B Decker, Zoe E Nelson, Amy Corveleyn, Priya K Gopalan, Kelly Irwin
Caring for Patients With Serious Mental Illness: Guide for the Oncology Clinician. Oncology (Williston Park, N.Y.) 36 (7) (2022)
Sarah A Holstein
Current Frontline Treatment of Multiple Myeloma. Oncology (Williston Park, N.Y.) 36 (7) (2022)

volume 36, number 8, 2022

Khaled W Kabbara, Timothy Cannon, Arthur Winer, Raymond C Wadlow
Molecular Pathogenesis of Cholangiocarcinoma: Implications for Disease Classification and Therapy. Oncology (Williston Park, N.Y.) 36 (8) (2022)
P Connor Johnson, Jeremy S Abramson
Current Treatment of Burkitt Lymphoma and High-Grade B-Cell Lymphomas. Oncology (Williston Park, N.Y.) 36 (8) (2022)

volume 36, number 9, 2022

Cristiane D Bergerot, Paulo Gustavo Bergerot, Lorena Nm Molina, David Lee, Errol J Philip, Barry D Bultz
Psycho-Oncology and the Relevance of a Biopsychosocial Screening Program. Oncology (Williston Park, N.Y.) 36 (9) (2022)
Amvrine Ganguly, Marco Michael, Simona Goschin, Kirk Harris, Daniel C McFarland
Cancer Pain and Opioid Use Disorder. Oncology (Williston Park, N.Y.) 36 (9) (2022)
Roy S Herbst
Future Directions in the Management of Non-Small Cell Lung Cancer Harboring Driver Mutations. Oncology (Williston Park, N.Y.) 36 (9) (2022)